Carl L. Gordon, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), bought 7,142,858 shares at $3.50 ($25.0M) on 2021-11-04, disclosed to the SEC on 2021-11-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.50 | 1,785,715 | $6.3M | 25.0% |
| 2 | $3.50 | 1,785,715 | $6.3M | 25.0% |
| 3 | $3.50 | 3,571,428 | $12.5M | 50.0% |
| Total | $3.50 avg | 7,142,858 | $25.0M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |